CITIUS ONCOLOGY, INC. (CTOR) › Weighted Average Diluted SharesCITIUS ONCOLOGY, INC. (CTOR) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2022-12-31: 1.34M2023-09-30: 67.50M2023-12-31: 6.60M2024-09-30: 68.05M2025-09-30: 73.27M73.27M2022-12-31Weighted Average Diluted Shares (shares)2025-09-30Period endedWeighted Average Diluted SharesChange YoYSource filing2025-09-3073.27M+7.7%2025-12-23From 2024-10-012024-09-3068.05M—2025-12-23From 2023-10-012023-12-316.60M—2024-04-16From 2023-01-012023-09-3067.50M—2024-12-27From 2022-10-012022-12-311.34M—2024-04-16From 2022-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)